The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Vimpat 150 mg film-coated tablets

UCB Pharma SAEU/1/08/470/7-9

Main Information

Trade NameVimpat 150 mg film-coated tablets
Active SubstancesLacosamide
Dosage FormFilm-coated tablet
Licence HolderUCB Pharma SA
Licence NumberEU/1/08/470/7-9

Group Information

ATC CodeN03AX Other antiepileptics
N03AX18 lacosamide


License statusAuthorised
Licence Issued29/08/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back